Monday, November 14, 2022 11:06:03 AM
This run is a bit more tame, with better accumulation, than the prior conference runs.
I am in the camp of folks that don't think SNO is going to bring anything new, but I do think that this price inflation is due to LL presenting the data (yes, even the same data as we've already seen). It is a 'confidence' factor.
Probably a strong chance that, though SNO isn't going to be the 'big event', this run holds and a new base is established for the next holding period. I would guess it gets close to a dollar, settles around mid $0.80's post conference, then holds there until commercial license.
- And no, that doesn't mean this is the journal article. It is saying that the abstracts are from the SNO journal article that contains all of the abstracts.
I am in the camp of folks that don't think SNO is going to bring anything new, but I do think that this price inflation is due to LL presenting the data (yes, even the same data as we've already seen). It is a 'confidence' factor.
Probably a strong chance that, though SNO isn't going to be the 'big event', this run holds and a new base is established for the next holding period. I would guess it gets close to a dollar, settles around mid $0.80's post conference, then holds there until commercial license.
- And no, that doesn't mean this is the journal article. It is saying that the abstracts are from the SNO journal article that contains all of the abstracts.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
